US 11,786,549 B2
Anti-inflammatory composition comprising graphene nano-structure
Kyung-Sun Kang, Seoul (KR); Byung-Chul Lee, Seoul (KR); Jin Young Lee, Seoul (KR); and Jong Bo Park, Seoul (KR)
Assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, Seoul (KR); and BIOGRAPHENE INC., Seoul (KR)
Appl. No. 16/766,514
Filed by SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, Seoul (KR); and BIOGRAPHENE INC., Seoul (KR)
PCT Filed Nov. 23, 2018, PCT No. PCT/KR2018/014557
§ 371(c)(1), (2) Date May 22, 2020,
.
Claims priority of application No. 10-2017-0158752 (KR), filed on Nov. 24, 2017; and application No. 10-2017-0158753 (KR), filed on Nov. 24, 2017.
Prior Publication US 2020/0360429 A1, Nov. 19, 2020
Int. Cl. A61K 33/44 (2006.01); A61P 37/06 (2006.01); A61K 9/16 (2006.01)
CPC A61K 33/44 (2013.01) [A61K 9/16 (2013.01); A61P 37/06 (2018.01)] 5 Claims
OG exemplary drawing
 
1. A method of treating an inflammatory bowel disease, comprising administering a composition comprising an active ingredient for treating the inflammatory bowel disease to a subject in need thereof, and thereby treating the inflammatory bowel disease,
wherein the active ingredient consists of nano-sized graphene oxide (nano-GO) or a graphene quantum dot (GQD),
wherein the active ingredient is plate-shaped particles,
and wherein the inflammatory bowel disease is selected from the group consisting of Crohn's disease and ulcerative colitis.